BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34546128)

  • 1. Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents.
    Richter H; Bücker P; Martin LF; Dunker C; Fingerhut S; Xia A; Karol A; Sperling M; Karst U; Radbruch A; Jeibmann A
    Radiology; 2021 Dec; 301(3):637-642. PubMed ID: 34546128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Richter H; Fingerhut S; Martin LF; Xia A; Henze N; Paulus W; Sperling M; Karst U; Jeibmann A
    Invest Radiol; 2019 Sep; 54(9):531-536. PubMed ID: 31261291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elemental Bioimaging of Sheep Bone and Articular Cartilage After Single Application of Gadolinium-Based Contrast Agents.
    Richter H; Verlemann C; Jeibmann A; Martin LF; Luebke AM; Karol A; Sperling M; Radbruch A; Karst U
    Invest Radiol; 2024 Apr; 59(4):287-292. PubMed ID: 37747456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
    Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium Presence in Rat Skin: Assessment of Histopathologic Changes Associated with Small Fiber Neuropathy.
    Boyken J; Lohrke J; Treu A; Neddens J; Jost G; Ulbrich HF; Balzer T; Frenzel T; Prokesch M; Thuss U; Pietsch H
    Radiology; 2024 Jan; 310(1):e231984. PubMed ID: 38226877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal Enhancement and Enhancement Kinetics of Gadobutrol, Gadoteridol, and Gadoterate Meglumine in Various Body Regions: A Comparative Animal Study.
    Knobloch G; Frenzel T; Pietsch H; Jost G
    Invest Radiol; 2020 Jun; 55(6):367-373. PubMed ID: 31985602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
    McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
    Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic Effects of Gadolinium Retention in the Brain after Gadolinium-based Contrast Agent Administration.
    Ayers-Ringler J; McDonald JS; Connors MA; Fisher CR; Han S; Jakaitis DR; Scherer B; Tutor G; Wininger KM; Dai D; Choi DS; Salisbury JL; Jannetto PJ; Bornhorst JA; Kadirvel R; Kallmes DF; McDonald RJ
    Radiology; 2022 Mar; 302(3):676-683. PubMed ID: 34931861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
    Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
    J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
    Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
    J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.